PCMP

Original Research

Real-World Comparative Effectiveness Assessment Study of a Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial and a Cryopreserved Cadaveric Skin Allograft for Use in Diabetic Foot Ulcers – A Non-inferiority Analysis

04/04/2024

Michael Leon Sabolinski , MD;

This study evaluated real-world effectiveness of PCMP versus CCSA in a large DFU patient population.

This study evaluated real-world...

04/04/2024

ePlasty

Original Research

Effectiveness of a Purified Type I Collagen Matrix Plus the Antimicrobial Polyhexamethylene Biguanide for Use in Cutaneous Wounds: Analysis of a Population of Three Combined Registries

09/25/2023

Michael Leon Sabolinski , MD;

George J. Koullias , MD;

Scott A. Gorenstein ;

Alisha Oropallo , MD, FACS, FSVS, FAPWCA, FABWMS;

Michael A. Bain , MD;

Researchers analyzed pooled data from the population of 3 combined registries to determine the effectiveness of a wound scaffold comprised of purified type I collagen matrix plus the antimicrobial polyhexamethylene biguanide to determine...

Researchers analyzed pooled data...

09/25/2023

Wounds

Case Study

A Single-Center Pilot Study Investigating the Effects of a Native Cross-Linked Extracellular Matrix with Polyhexamethylene Biguanide to Manage Chronic Lower Extremity Wounds Exhibiting Bacterial Contamination

05/03/2023

Windy E. Cole , DPM, CWSP, FACCWS;

Janina Krumbeck , PhD;

Christopher Schattinger , PhD;

05/03/2023

Wound Management & Prevention

VIDEO

Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial for VLUs

06/12/2022

Dr Michael Sabolinski discusses the findings of a secondary analysis of patients with VLUs who participated in the RESPOND Registry

Dr Michael Sabolinski discusses...

06/12/2022

Wound Management & Prevention

Original Research

Effectiveness of Type I Collagen Matrix Plus Polyhexamethylene Biguanide Antimicrobial for the Treatment of Pressure Injuries

05/31/2022

Kerry T. Thibodeaux , MD;

Michael J. Menack ;

Michael Leon Sabolinski , MD;

Carlos Trabanco , MD;

The authors describe the effects of PCMP in the subgroup of patients with pressure injuries from the RESPOND registry.

The authors describe the effects...

05/31/2022

Wounds

Mixed Venous Arterial Disease Right Lower Extremity Chronic Ulcer Treated With An Innovative Dehydrated Human Umbilical Cord Expandable (dHUC EX) Allograft

Introduction: Venous leg ulcers (VLUs), although common, are often mismanaged due to errors of not correctly diagnosing the arterial insufficiency component. In fact, mixed arterial venou...

William Tettelbach , MD, FACP, FIDSA, FUHM, CWS;

Eddie Lipan , MD;

Ritu Gothwal , MD;

08/19/2021

Effectiveness of a native Type I Collagen matrix plus polyhexamethylene biguanide (PHMB) antimicrobial in the treatment of pressure injuries in a real-world setting

Objective: To analyze the subgroup of Pressure Injuries (PRIs) in the 28 site, prospective, non-interventional, PCMP registry (RESPOND)(a) that evaluated the real-world effectiveness of P...

Kerry T. Thibodeaux , MD;

Michael J. Menack ;

Michael Leon Sabolinski , MD;

Carlos Trabanco , MD;

08/19/2021

A comparative effectiveness research study of a native Type I collagen matrix plus polyhexamethylene biguanide antimicrobial and a cryopreserved cadaveric skin allograft for use in diabetic foot ulcers – a non-inferiority analysis

OBJECTIVE: Real-world effectiveness was evaluated in a large patient population at 246 US treatment facilities comparing a purified native cross-linked extracellular matrix plus polyhexam...

Kerry T. Thibodeaux , MD;

Michael Leon Sabolinski , MD;

08/19/2021